Treatment and monitoring of SAGE-DM Currently, there is no specific evidence-based treatment algorithm for SAGE-DM However, the management of SAGE-DM should be adapted from geriatric diabetes guidelines, considering the underlying aging mechanisms that may affect the response to treatment The following recommendations can thus be viewed as an adaptation of standard care within the SAGE-DM conceptual framework rather than a fully validated treatment pathway Monitoring HbA1c may be unreliable in in the elderly due to comorbidities affecting red blood cell lifespan (e.g., advanced kidney disease, GI bleeding, heart valve defects)
As discussed in the CY 2026 OPPS/ASC proposed rule, hospitals that do not negotiate payment rates and only receive non-negotiated payments for service would be exempted from this data collection
Heres how Sublingual B12 works: sublingual forms of B12 whether in liquid or tablet form are placed under the tongue
Meal composition: Lean protein first (reduces nausea), then vegetables, then small amount of complex carbs
TB-500 Component (Thymosin Beta-4 Fragment 17-23, acetylated)
